BIRC5 and neoplasm: The baculoviral inhibitor of the apoptosis repeat-containing protein 5 (BIRC5) gene (also known as survivin), a well-known target gene for cancer therapy, is involved in controlling multiple signaling pathways in tumor cells and has the dual function of inhibiting apoptosis and promoting cell proliferation (22).